Andere talen Pharming Group N.V.

Aandelen

PHARM

NL0010391025

Beurs gesloten - Euronext Amsterdam Andere beurzen 17:35:00 26-04-2024			Nabeurs 21:58:01
0,9 ^EUR	+2,16%		0,901	+0,11%

23/04	AEX in het groen ondanks koersval Akzo en Randstad	AM
22/04	Prosus geeft impuls aan AEX	AM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Pharming N : Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025 - Form 6-K	25/04
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders 2024 Rare Impact Awards	25/04
Pharming N : to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards - Form 6-K	24/04
Pharming N : Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards	24/04
Pharming Group to report first quarter 2024 financial results on May 8	24/04
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards	24/04
Pharming Group to Buy Back EUR123 Million of Bonds due 2025	22/04
Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025	19/04
Pharming N : Pharming Group announces the placement of €100 million convertible bonds due 2029	19/04
Pharming Group announces the placement of €100 million convertible bonds due 2029	18/04
Pharming Group to Issue EUR100 Million Convertible Bonds, Repurchase EUR125 Million Bonds	18/04
Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025	18/04
Pharming Group N.V. announced that it expects to receive ?100 million in funding	18/04
Pharming Group N.V. Announces Completion of Enrollment in Pediatric Clinical Trial of Leniolisib	08/04
Pharming Group Finishes Enrolling Patients for Phase 3 Pediatric Testing of its Treatment for Rare Auto-Immune Disorder	08/04
Pharming N : Pharming announces completion of enrollment in pediatric clinical trial of leniolisib	08/04
Pharming announces completion of enrollment in pediatric clinical trial of leniolisib	08/04
Pharming N : Pharming Group announces the 2024 Annual General Meeting of Shareholders	04/04
Pharming N : Pharming Group announces the filing of its 2023 Annual Report and Form 20-F	04/04
Pharming N : Notice to Convene AGM 2024	04/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Pharming Group N.V.

Aandelen

PHARM

NL0010391025

Andere talen

Filters